Indications and uses
To relieve the symptoms of weakness.
To relieve the symptoms of weakness.
Adults: 4 drops into a tsp. of water 3 times a day. Children: 1/2 dose. Repeat at greater intervals as condition subsides. Or as directed bya lic. practitioner.
ASTRAGALUS
To relieve the symptoms of weakness.
Keep this and all medicines out of reach of children.
Indications:
ASTRAGALUS Weakness
If symptoms persist/worsen or if pregnant/nursing, consult your practitioner.
Adults: 4 drops into a tsp. of water 3 times a day. Children: 1/2 dose. Repeat at greater intervals as condition subsides. Or as directed bya lic. practitioner.
Sucrose/Lactose
The OTC potency range of ASTRAGALUS is 2x–30x, 1c–30c, 200c, 1m, 10m, 50m, and CM.
Availability is subject to change.
All WHP single remedies are made to order; thus, the labels are printed on the same label stock, as the orders are filled.
‘Bottle Size,’ ‘Potency,’ and ‘Alcohol Percentage’ vary on the label depending on customer choice.
Standard bottle sizes for dilution-form remedies are 15ml, 30ml, 50ml, and 100ml.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0740640240380 | GTIN-13: 0740640240380 EAN-13: 0740640240380 GTIN-12: 740640240380 UPC-A: 740640240380 GTIN storage (14 digits): 00740640240380 | Astragalus.jpg |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71919-097 | 71919-097-07, 71919-097-08, 71919-097-09, 71919-097-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| ASTRAGALUS NUTTALLII LEAF | NC1P15G4KZ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| da6d1336-ece0-5806-e053-2995a90a588a | cef7c574-a7d6-4068-af3a-b9d3c3bb2ffc | 2022-03-17 | Warnings | cef7c574-a7d6-4068-af3a-b9d3c3bb2ffc |
Adverse event summaries are temporarily unavailable. Other product information remains available.